España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Dr Reddy's Laboratories
RDY
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.24
0
0.00%
Pre-Market: 4:00 PM EDT
Get Report
Comment
Dr Reddy's Laboratories (RDY) Forecast
News
Earnings
Dr Reddy's Laboratories (RDY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dr Reddy's Laboratories (NYSE:RDY) Stock
Dr Reddy's Laboratories Stock (NYSE: RDY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 05, 2024
Dr. Reddy's Lab Delivers 'Another Good Quarter,' CEO Says As Revenue Jumps 17%
Vandana Singh
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk
Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.1...
Benzinga Newsdesk
Tuesday, October 08, 2024
Dr. Reddy's Subsidiary Aurigene Oncology, Ann...
Benzinga Newsdesk
Wednesday, October 02, 2024
Dr. Reddy's Signs Voluntary Licensing Agreeme...
Benzinga Newsdesk
Friday, September 13, 2024
Dr. Reddy's Laboratories Agreed To Partially ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Dr. Reddy's Issues Clarification Regarding Al...
Benzinga Newsdesk
Friday, August 23, 2024
Dr. Reddy's Receives FDA Form 483 With Three ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Dr. Reddy's Laboratories, Aurigene Pharmaceut...
Benzinga Newsdesk
Tuesday, July 30, 2024
Barclays Maintains Overweight on Dr Reddy's L...
Benzinga Newsdesk
Monday, July 29, 2024
Dr. Reddy's Receives Positive CHMP Opinion Fr...
Benzinga Newsdesk
Dr Reddy's Laboratories Q1 2025 GAAP EPS ₹83....
Benzinga Newsdesk
Thursday, July 18, 2024
Dr. Reddy's Signs Non-Exclusive Patent Licens...
Benzinga Newsdesk
Thursday, June 27, 2024
Dr. Reddy's to Acquire Haleon's Nicotine Addiction Drug
Zacks
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk
Wednesday, June 26, 2024
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
Vandana Singh
Haleon Sells Its Nicotine Replacement Therapy...
Benzinga Newsdesk
Dr. Reddy's To Acquire Haleon's Global Portf...
Benzinga Newsdesk
Dr. Reddy's Laboratories Switzerland Acquires...
Benzinga Newsdesk
Friday, June 07, 2024
Dr Reddy's Laboratories Says USFDA Completed ...
Benzinga Newsdesk
Tuesday, May 21, 2024
Alvotech And Dr. Reddy's Enter Collaboratoin ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Barclays Maintains Overweight on Dr Reddy's L...
Benzinga Newsdesk
Tuesday, May 07, 2024
Dr Reddy's Laboratories shares are trading lo...
Benzinga Newsdesk
Dr Reddy's Laboratories Q4 EPS $0.94 Beats $0...
Benzinga Newsdesk
Dr Reddy's Laboratories Q4 2024 GAAP EPS ₹78....
Benzinga Newsdesk
Friday, May 03, 2024
Dr. Reddy's Laboratories Announces Launch Of ...
Benzinga Newsdesk
Thursday, April 25, 2024
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk
Nestlé India And Dr. Reddy's To Form Joint Ve...
Benzinga Newsdesk
Wednesday, April 10, 2024
Dr. Reddy's Launches Drug-Free Migraine Manag...
Benzinga Newsdesk
Friday, April 05, 2024
Dr. Reddy's Laboratories Ltd. And Bayer Enter...
Benzinga Newsdesk
Wednesday, March 27, 2024
Dr Reddy's Entered Into Exclusive Distributio...
Charles Gross
Friday, March 22, 2024
Dr. Reddy's Laboratories Inks Pact With Pharm...
Benzinga Newsdesk
Thursday, February 22, 2024
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
Vandana Singh
Wednesday, January 31, 2024
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk
Dr. Reddy Q3 2024 EPS Rs82.68 Up From Rs74.95...
Benzinga Newsdesk
Tuesday, January 30, 2024
Dr Reddy's Laboratories: Q3 Earnings Insights
Benzinga Insights
Dr Reddy's Laboratories Q3 EPS $0.99 Beats $0...
Benzinga Newsdesk
Monday, January 29, 2024
Barclays Maintains Overweight on Dr Reddy's L...
Benzinga Newsdesk
Tuesday, January 16, 2024
Dr Reddy's Laboratories Issues Response Regar...
Benzinga Newsdesk
Wednesday, January 03, 2024
Dr. Reddy's Announces The Acquisition of Meno...
Benzinga Newsdesk
Thursday, December 14, 2023
Dr. Reddy's Becomes First Indian Pharma Compa...
Benzinga Newsdesk
Monday, December 11, 2023
Dr. Reddy's shares are trading lower after th...
Benzinga Newsdesk
Reported Earlier, 'India's Dr. Reddy's Shares...
Benzinga Newsdesk
Wednesday, December 06, 2023
Dr. Reddy's To Make $7.5M Upfront Payment To ...
Benzinga Newsdesk
Coya Therapeutics And Dr. Reddy's Laboratorie...
Benzinga Newsdesk
Thursday, November 16, 2023
Dr. Reddy's Laboratories Announced The Roll-o...
Benzinga Newsdesk
Thursday, October 12, 2023
Dr. Reddy's Laboratories Says "FDA Today Comp...
Benzinga Newsdesk
Wednesday, August 23, 2023
Top 5 Health Care Stocks That May Fall Off A Cliff
Lisa Levin
Wednesday, July 26, 2023
Dr Reddy's Laboratories Q1 EPS $1.02 Beats $0...
Benzinga Newsdesk
Wednesday, July 12, 2023
Dr Reddy's Proposed Rituximab Biosimilar Appl...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
